tradingkey.logo

Novo Selects Gefion AI Supercomputer To Advance Drug Discovery, Innovation

ReutersJun 11, 2025 11:06 AM

- Novo Nordisk A/S NOVOb.CO:

  • NOVO NORDISK SELECTS GEFION AI SUPERCOMPUTER TO ADVANCE DRUG DISCOVERY AND HEALTHCARE INNOVATION

  • WILL GAIN ACCESS TO GEFION'S COMPUTATIONAL CAPABILITIES TO PROCESS VAST DATASETS

  • NOVO NORDISK HAS MADE AI A STRATEGIC FOCUS ACROSS ITS VALUE CHAIN AND GEFION WILL PLAY A KEY ROLE IN EXECUTION OF THESE COMPUTE-INTENSIVE PROJECTS

  • PARTIES SIGN MULTIYEAR AGREEMENT

Further company coverage: [NOVOb.CO]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI